Zobrazeno 1 - 10
of 22
pro vyhledávání: '"B Rodriguez Vargas"'
Autor:
C Cáceres-Velasco, MÁ Amor-García, A Melgarejo-Ortuño, R Moreno-Diaz, E Matilla-García, B Rodriguez-Vargas, CA Apezteguia Fernandez, MP Bautista Sanz
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::293149b39b7b579f63e16ce1d31aa0f0
https://doi.org/10.1136/ejhpharm-2023-eahp.194
https://doi.org/10.1136/ejhpharm-2023-eahp.194
Autor:
C Apezteguia Fernandez, MP Bautista Sanz, A Melgarejo Ortuño, E Matilla Garcia, B Rodriguez Vargas, C de Caceres Velasco, MA Amor Garcia, R Moreno Diaz
Publikováno v:
Section 3: Production and compounding.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2245b3cfc779f0d16f2acc845393c540
https://doi.org/10.1136/ejhpharm-2023-eahp.44
https://doi.org/10.1136/ejhpharm-2023-eahp.44
Autor:
A Melgarejo-Ortuño, JJ Alcaraz Sanchez, CA Apezteguia Fernández, MDP Bautista Sanz, C de Caceres Velasco, E Matilla Garcia, B Rodriguez Vargas, MA Amor Garcia, R Moreno Diaz
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52168f37b91c30b389ca472276fb7613
https://doi.org/10.1136/ejhpharm-2022-eahp.176
https://doi.org/10.1136/ejhpharm-2022-eahp.176
Autor:
C. Apezteguia Fernández, B Rodriguez Vargas, M.P. Bautista Sanz, E. Matilla García, R. Moreno Díaz
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Elderly patients are fragile and often polymedicated. These characteristics, added to an oncologic process, could generate an increased risk of adverse effects of drugs. Aim and objectives The aim of this study was to identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0c5a3c79b658dedacf80fdf73416f94
https://doi.org/10.1136/ejhpharm-2020-eahpconf.383
https://doi.org/10.1136/ejhpharm-2020-eahpconf.383
Autor:
M.P. Bautista Sanz, C. Apezteguia Fernández, E. Matilla García, L Esteban del Hoyo, R. Moreno Díaz, B Rodriguez Vargas, I Santaolalla Garcia
Publikováno v:
Eur J Hosp Pharm
Background Interferon-free combination direct-acting antivirals (DAAs) regimens have improved tolerability and efficacy for HCV-infected patients but it is necesary to check drug-drug interactions (DDIs) because they have the potential to cause toxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9433368aefc135d2c1ed6186d9775a35
https://doi.org/10.1136/ejhpharm-2018-eahpconf.186
https://doi.org/10.1136/ejhpharm-2018-eahpconf.186
Publikováno v:
Farmacia Hospitalaria. 35:47-49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f499f34b3552f9cb53751ebd999be92a
https://doi.org/10.1016/j.farma.2010.02.005
https://doi.org/10.1016/j.farma.2010.02.005
Publikováno v:
European Journal of Hospital Pharmacy. 23:A40.3-A41
Background The use of generic alternatives to antiretroviral branded drugs may lead to substantial cost savings. However, this strategy could increase pill burden and may reduce adherence and potentially decrease virologic suppression rates. Purpose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::034ac97be22ebcbbf1b39ffe1e3d62e0
https://doi.org/10.1136/ejhpharm-2016-000875.93
https://doi.org/10.1136/ejhpharm-2016-000875.93
Autor:
E Tortajada Esteban, MA Arias Moya, MI Panadero Esteban, B Rodriguez Vargas, E Castillo Bazán, G Toledano Mayoral, FJ Bécares Martínez, M Bonilla Porras, M Hernández Segurado, M Gomez Perez, EM Martín Gozalo
Publikováno v:
European Journal of Hospital Pharmacy. 21:A32.1-A32
Background The administration of glutamine (GLU) intravenously as part of protein intake in patients who are given parenteral nutrition (PN) is associated with fewer infectious complications, shorter hospital stay and, possibly, reduced mortality in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a4483f528005fe09f366c4761cc5902
https://doi.org/10.1136/ejhpharm-2013-000436.76
https://doi.org/10.1136/ejhpharm-2013-000436.76
Autor:
E Castillo Bazán, G Toledano Mayoral, M Bonilla Porras, EM Martín Gozalo, B Rodriguez Vargas, MI Panadero Esteban, E Tortajada Esteban, M Gomez Perez, M Hernández Segurado, L Prieto Borja, J. Bécares Martínez, MA Arias Moya
Publikováno v:
European Journal of Hospital Pharmacy. 21:A94.2-A94
Background Daptomycin’s licensed indications are complicated skin and soft tissue infections (cSSTI), right-sided endocarditis due to Staphylococcus aureus (SA) and bacteraemia associated with emerging infectious diseases [EID] or cSSTI. Vancomycin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93891496a580976c1c9c2e95f4cdcb6e
https://doi.org/10.1136/ejhpharm-2013-000436.231
https://doi.org/10.1136/ejhpharm-2013-000436.231
Publikováno v:
European Journal of Hospital Pharmacy. 21:A177.1-A177
Background Transitions of care are high risk points for medicines errors, so that medicines reconciliation is essential for improving drug safety. It consists of identifying the most accurate list of the patient’s medicines and comparing it to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88b0de4f38f167a6db5f76c9d96a7aa5
https://doi.org/10.1136/ejhpharm-2013-000436.434
https://doi.org/10.1136/ejhpharm-2013-000436.434